Skip to content

Author

Takefumi Kimura

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A multicenter multistate modeling on the natural history of liver decompensation: Longitudinal analysis of 1777 patients

Background: Cirrhosis often remains silent until decompensation, after which survival deteriorates sharply. Contemporary, transition-aware estimates are limited, especially in Asian-predominant cohorts. We analyzed trajectories from compensated advanced chronic liver disease (cACLD) through sequential decompensations t...

E. Tan, N. S. Tang, N. Syn et al. · 0 citations
Open access Oct 2026

Effects of imeglimin on liver enzymes and body composition in patients with MASLD and type 2 diabetes: a pilot study

Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent in patients with type 2 diabetes mellitus (T2DM), yet effective pharmacological options remain limited. Imeglimin, a novel antidiabetic agent targeting mitochondrial bioenergetics, has shown potential hepatoprotective effects in precli...

Kaede Fujita, Takanobu Iwadare, Takefumi Kimura et al. · 0 citations
Open access Aug 2026

Machine learning for population-level risk prediction of future cholangiocarcinoma

It is shown that ML models integrating biliary-disease associated health records and Gamma glutamyltransferase can stratify risk of future CCA, and demonstrates the potential of data-driven models in personalised screening for hepatobiliary cancer.

F. van Haag, J. Clusmann, Paul-Henry Koop et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.